Healthcare is investing billions in AI, yet most projects fail to scale. This analysis examines the EMR Divide and why only 4 ...

A widely prescribed opioid painkiller showed limited effectiveness and increased risk of negative effects in a new analysis ...

Small businesses are juggling too many AI tools. Learn how to audit your AI stack, cut redundant subscriptions, and stop AI ...

Learn how to analyze a company’s fundamentals, understand what drives its value, and discover how fundamental analysis helps ...

CytomX Therapeutics, Inc. is downgraded to Hold ahead of key CX-2051 Phase 1 expansion data in 1Q26. Learn more about CTMX ...

Gina Mastantuono, president and CFO, ServiceNow: “In 2026, AI will be judged less on promise and more on proof. Enterprises ...

Upcoming software purchases should no longer be one-time contracts; they're living partnerships built on shared data and trust.

Altimmune's pemvidutide shows strong Phase IIb results for MASH, promising Phase III prospects. Read here for more analysis ...

In the third quarter — that’s July, August, and September — the U.S. economy was growing pretty fast. Gross domestic product ...

Dayton Daily News reporters delivered hard-hitting investigations in 2025, holding powerful people and institutions accountable, watching your tax dollars and helping you understand what’s really ...

The throughline of the discussion is clear. AI’s economic promise is real, but conditional. Productivity gains will not flow from better models alone. They depend on redesigning work, investing in ...